Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Wolfgang Kühn
Woman Max 99 years
Wolfgang Kühn
Update Il y a 5 ans
A Drug-drug Interaction Study to Investigate the Effects of AZD1981 on the Metabolism and Pharmacodynamics of Oral Contraceptives
The primary purpose of this study is to determine whether the treatment with AZD1981 will affect the metabolism of hormones included in oral contraceptives.
Country
None
organs
None
Specialty
None
Closed trial
More information
Man Max 99 years
Wolfgang Kühn, MD
Update Il y a 5 ans
A Study to Assess the Safety, Tolerability and Pharmacokinetics After Single Ascending Intravenous Doses of AZD2927 in Healthy Male Volunteers
In this early phase study, healthy male volunteers will be randomly assigned to one dose of either AZD2927 or placebo. The objective will be to assess the Safety,Tolerability and Pharmacok...
Country
None
organs
None
Specialty
None
Closed trial
More information
Man Max 99 years
Wolfgang Kühn
Update Il y a 6 ans
Determine Central 5-HT1B Receptor Occupancy of ZOMIG® Rapimelt (Zolmitriptan) in Healthy Male Volunteers
The purpose of this study is to determine the central 5-HT1B receptor occupancy of ZOMIG® Rapimelt (zolmitriptan) in healthy male volunteers.
Country
Sweden
organs
None
Specialty
None
Closed trial
More information
Man Max 99 years
Wolfgang Kühn
Update Il y a 5 ans
AZD8075 Study to Assess the Safety, Tolerability and Pharmacokinetics of Multiple Ascending Oral Doses of AZD8075 in Healthy Male Volunteers
The aims of the study are to evaluate the safety, tolerability and pharmacokinetics of AZD8075 in healthy male subjects at increasing doses when given for 14 days
Country
None
organs
None
Specialty
None
Closed trial
More information
Man Max 99 years
Wolfgang Kühn
Update Il y a 5 ans
AZD8075 Single Ascending Dose Study
The aim of this study is to assess the safety, tolerability and pharmacokinetics of single ascending oral doses of AZD8075 in healthy male volunteers
Country
Sweden
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Wolfgang Kühn, MD
Update Il y a 5 ans
A Bioavailability Study Comparing 3 Different AZD1981 Tablets
The purpose of this study is to study the relative bioavailability of AZD1981 when using a new tablet compared to the current tablet.
Country
Sweden
organs
None
Specialty
None
Closed trial
More information
Woman Max 99 years
Wolfgang Kühn, MD
Update Il y a 5 ans
Evaluation of Histamine H3 Receptor Radioligand [11C]AZ12807110 and Histamine H3 Receptor Occupancy of AZD5213 After Oral Administration
The purpose of this study is to investigate features of radioligand [11C]AZ12807110 and how much AZD5213 displaces radioligand from histamine receptors when given together.
Country
None
organs
None
Specialty
None
Closed trial
More information
Man Max 99 years
Wolfgang Kühn
Update Il y a 5 ans
A First Time in Man, Study to Assess the Safety of AZD8329 After Single Ascending Oral Doses
The primary objective for this study is to assess the safety and tolerability of AZD8329 when given as a single dose in increasing dose strength, and also to identify the highest tolerated...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Wolfgang Kühn
Update Il y a 5 ans
Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD0328 in Elderly Healthy Subjects
The primary purpose of this study is to investigate the safety and tolerability of AZD0328 following once-daily dosing for 13 days in elderly healthy volunteers and to define maximum toler...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Wolfgang Kühn, MD
Update Il y a 5 ans
A Study to Evaluate P-Glucose, Safety and Tolerability After Oral Single Dosing of AZD6370 in Type 2 Diabetic Patients
The purpose of this study is to assess the effect of AZD6370 on blood sugar and to study safety and tolerability in patients with type 2 diabetes.
Country
Sweden
organs
None
Specialty
None
Closed trial
More information
1
2
Next